OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia

HTML

Year: 2017
Type: article
Study design: Observational Study
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/j.clml.2017.08.101
Authors: Rita Assi, Hagop Kantarjian, Nicholas J. Short, Naval Daver, Koichi Takahashi, Guillermo Garcia-Manero, Courtney DiNardo, Jan Burger, Jorge Cortes, Nitin Jain, William Wierda, Salim Chamoun, Marina Konopleva, Elias Jabbour
Institution: The University of Texas MD Anderson Cancer Center
Language: English

Topic: Acute Lymphoblastic Leukemia research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: blinatumomab, tyrosine kinase inhibitors, Philadelphia chromosome-positive leukemia, relapsed/refractory acute lymphoblastic leukemia, ponatinib, dasatinib, bosutinib, minimal residual disease, cytokine release syndrome, combination therapy
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2745344769
FWCI: 16.52
Cites: 21
Cited by: 166
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms